APO Research
Talk to an analyst

APO RESEARCH · REPORT

HPV Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global HPV Vaccines Market Analysis and Forecast 2026-2032

22 December 2025193 pages

Choose your research edition.

Industry ResearchHPV Vaccines Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal HPV Vaccines Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal HPV Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HPV Vaccines Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal HPV Vaccines Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global HPV Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for HPV Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for HPV Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for HPV Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for HPV Vaccines is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of HPV Vaccines include Johnson & Johnson, Merck, Pfizer, GlaxoSmithKline, Serum Institute, Sanofi Pasteur, MedImmune, Emergent BioSolutions and CSL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for HPV Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HPV Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for HPV Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HPV Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HPV Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for HPV Vaccines sales, projected growth trends, production technology, application and end-user industry.

HPV Vaccines Segment by Company

Johnson & Johnson

Merck

Pfizer

GlaxoSmithKline

Serum Institute

Sanofi Pasteur

MedImmune

Emergent BioSolutions

CSL

Astellas Pharma

HPV Vaccines Segment by Type

Adolescents

Adults

HPV Vaccines Segment by Application

Male

Female

HPV Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HPV Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HPV Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HPV Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of HPV Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of HPV Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HPV Vaccines sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HPV Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Adolescents Major Manufacturers Table 3. Adults Major Manufacturers Table 4. Global HPV Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Male Major Manufacturers Table 6. Female Major Manufacturers Table 7. HPV Vaccines Industry Trends Table 8. HPV Vaccines Industry Drivers Table 9. HPV Vaccines Industry Opportunities and Challenges Table 10. HPV Vaccines Industry Restraints Table 11. Global HPV Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global HPV Vaccines Revenue by Region (2021-2026) & (US$ Million) Table 13. Global HPV Vaccines Revenue by Region (2027-2032) & (US$ Million) Table 14. Global HPV Vaccines Revenue Market Share by Region (2021-2026) Table 15. Global HPV Vaccines Revenue Market Share by Region (2027-2032) Table 16. Global HPV Vaccines Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global HPV Vaccines Sales by Region (2021-2026) & (k units) Table 18. Global HPV Vaccines Sales by Region (2027-2032) & (k units) Table 19. Global HPV Vaccines Sales Market Share by Region (2021-2026) Table 20. Global HPV Vaccines Sales Market Share by Region (2027-2032) Table 21. Global HPV Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global HPV Vaccines Revenue Market Share by Manufacturers (2021-2026) Table 23. Global HPV Vaccines Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global HPV Vaccines Sales Market Share by Manufacturers (2021-2026) Table 25. Global HPV Vaccines Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global HPV Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global HPV Vaccines Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global HPV Vaccines Manufacturers, Product Type & Application Table 29. Global HPV Vaccines Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global HPV Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global HPV Vaccines Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global HPV Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 34. Global HPV Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 35. Global HPV Vaccines Revenue Market Share by Type (2021-2026) Table 36. Global HPV Vaccines Revenue Market Share by Type (2027-2032) Table 37. Global HPV Vaccines Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global HPV Vaccines Sales by Type (2021-2026) & (k units) Table 39. Global HPV Vaccines Sales by Type (2027-2032) & (k units) Table 40. Global HPV Vaccines Sales Market Share by Type (2021-2026) Table 41. Global HPV Vaccines Sales Market Share by Type (2027-2032) Table 42. Global HPV Vaccines Price by Type (2021-2026) & (US$/unit) Table 43. Global HPV Vaccines Price by Type (2027-2032) & (US$/unit) Table 44. Global HPV Vaccines Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global HPV Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 46. Global HPV Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 47. Global HPV Vaccines Revenue Market Share by Application (2021-2026) Table 48. Global HPV Vaccines Revenue Market Share by Application (2027-2032) Table 49. Global HPV Vaccines Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global HPV Vaccines Sales by Application (2021-2026) & (k units) Table 51. Global HPV Vaccines Sales by Application (2027-2032) & (k units) Table 52. Global HPV Vaccines Sales Market Share by Application (2021-2026) Table 53. Global HPV Vaccines Sales Market Share by Application (2027-2032) Table 54. Global HPV Vaccines Price by Application (2021-2026) & (US$/unit) Table 55. Global HPV Vaccines Price by Application (2027-2032) & (US$/unit) Table 56. Johnson & Johnson Company Information Table 57. Johnson & Johnson Business Overview Table 58. Johnson & Johnson HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Johnson & Johnson HPV Vaccines Product Portfolio Table 60. Johnson & Johnson Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Merck HPV Vaccines Product Portfolio Table 65. Merck Recent Development Table 66. Pfizer Company Information Table 67. Pfizer Business Overview Table 68. Pfizer HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Pfizer HPV Vaccines Product Portfolio Table 70. Pfizer Recent Development Table 71. GlaxoSmithKline Company Information Table 72. GlaxoSmithKline Business Overview Table 73. GlaxoSmithKline HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. GlaxoSmithKline HPV Vaccines Product Portfolio Table 75. GlaxoSmithKline Recent Development Table 76. Serum Institute Company Information Table 77. Serum Institute Business Overview Table 78. Serum Institute HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Serum Institute HPV Vaccines Product Portfolio Table 80. Serum Institute Recent Development Table 81. Sanofi Pasteur Company Information Table 82. Sanofi Pasteur Business Overview Table 83. Sanofi Pasteur HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Sanofi Pasteur HPV Vaccines Product Portfolio Table 85. Sanofi Pasteur Recent Development Table 86. MedImmune Company Information Table 87. MedImmune Business Overview Table 88. MedImmune HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. MedImmune HPV Vaccines Product Portfolio Table 90. MedImmune Recent Development Table 91. Emergent BioSolutions Company Information Table 92. Emergent BioSolutions Business Overview Table 93. Emergent BioSolutions HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Emergent BioSolutions HPV Vaccines Product Portfolio Table 95. Emergent BioSolutions Recent Development Table 96. CSL Company Information Table 97. CSL Business Overview Table 98. CSL HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. CSL HPV Vaccines Product Portfolio Table 100. CSL Recent Development Table 101. Astellas Pharma Company Information Table 102. Astellas Pharma Business Overview Table 103. Astellas Pharma HPV Vaccines Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Astellas Pharma HPV Vaccines Product Portfolio Table 105. Astellas Pharma Recent Development Table 106. North America HPV Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 107. North America HPV Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 108. North America HPV Vaccines Sales by Type (2021-2026) & (k units) Table 109. North America HPV Vaccines Sales by Type (2027-2032) & (k units) Table 110. North America HPV Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 111. North America HPV Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 112. North America HPV Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 113. North America HPV Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 114. North America HPV Vaccines Sales by Application (2021-2026) & (k units) Table 115. North America HPV Vaccines Sales by Application (2027-2032) & (k units) Table 116. North America HPV Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 117. North America HPV Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 118. North America HPV Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. North America HPV Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 120. North America HPV Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 121. North America HPV Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 122. North America HPV Vaccines Sales by Country (2021-2026) & (k units) Table 123. North America HPV Vaccines Sales by Country (2027-2032) & (k units) Table 124. North America HPV Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 125. North America HPV Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 126. United States HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 127. Canada HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 128. Mexico HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 129. Europe HPV Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe HPV Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe HPV Vaccines Sales by Type (2021-2026) & (k units) Table 132. Europe HPV Vaccines Sales by Type (2027-2032) & (k units) Table 133. Europe HPV Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 134. Europe HPV Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 135. Europe HPV Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe HPV Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe HPV Vaccines Sales by Application (2021-2026) & (k units) Table 138. Europe HPV Vaccines Sales by Application (2027-2032) & (k units) Table 139. Europe HPV Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 140. Europe HPV Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 141. Europe HPV Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe HPV Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe HPV Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe HPV Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 145. Europe HPV Vaccines Sales by Country (2021-2026) & (k units) Table 146. Europe HPV Vaccines Sales by Country (2027-2032) & (k units) Table 147. Europe HPV Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 148. Europe HPV Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 149. Germany HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 150. France HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 151. U.K. HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 152. Italy HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 153. Russia HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 154. Spain HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 155. Netherlands HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 156. Switzerland HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 157. Sweden HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 158. Poland HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 159. China HPV Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 160. China HPV Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 161. China HPV Vaccines Sales by Type (2021-2026) & (k units) Table 162. China HPV Vaccines Sales by Type (2027-2032) & (k units) Table 163. China HPV Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 164. China HPV Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 165. China HPV Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 166. China HPV Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 167. China HPV Vaccines Sales by Application (2021-2026) & (k units) Table 168. China HPV Vaccines Sales by Application (2027-2032) & (k units) Table 169. China HPV Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 170. China HPV Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 171. Asia HPV Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 172. Asia HPV Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 173. Asia HPV Vaccines Sales by Type (2021-2026) & (k units) Table 174. Asia HPV Vaccines Sales by Type (2027-2032) & (k units) Table 175. Asia HPV Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 176. Asia HPV Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 177. Asia HPV Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 178. Asia HPV Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 179. Asia HPV Vaccines Sales by Application (2021-2026) & (k units) Table 180. Asia HPV Vaccines Sales by Application (2027-2032) & (k units) Table 181. Asia HPV Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 182. Asia HPV Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 183. Asia HPV Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 184. Asia HPV Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 185. Asia HPV Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 186. Asia HPV Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 187. Asia HPV Vaccines Sales by Country (2021-2026) & (k units) Table 188. Asia HPV Vaccines Sales by Country (2027-2032) & (k units) Table 189. Asia HPV Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 190. Asia HPV Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 191. Japan HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 192. South Korea HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 193. India HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 194. Australia HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 195. Taiwan HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 196. Southeast Asia HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 197. SAMEA HPV Vaccines Revenue by Type (2021-2026) & (US$ Million) Table 198. SAMEA HPV Vaccines Revenue by Type (2027-2032) & (US$ Million) Table 199. SAMEA HPV Vaccines Sales by Type (2021-2026) & (k units) Table 200. SAMEA HPV Vaccines Sales by Type (2027-2032) & (k units) Table 201. SAMEA HPV Vaccines Sales Price by Type (2021-2026) & (US$/unit) Table 202. SAMEA HPV Vaccines Sales Price by Type (2027-2032) & (US$/unit) Table 203. SAMEA HPV Vaccines Revenue by Application (2021-2026) & (US$ Million) Table 204. SAMEA HPV Vaccines Revenue by Application (2027-2032) & (US$ Million) Table 205. SAMEA HPV Vaccines Sales by Application (2021-2026) & (k units) Table 206. SAMEA HPV Vaccines Sales by Application (2027-2032) & (k units) Table 207. SAMEA HPV Vaccines Sales Price by Application (2021-2026) & (US$/unit) Table 208. SAMEA HPV Vaccines Sales Price by Application (2027-2032) & (US$/unit) Table 209. SAMEA HPV Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 210. SAMEA HPV Vaccines Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 211. SAMEA HPV Vaccines Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 212. SAMEA HPV Vaccines Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 213. SAMEA HPV Vaccines Sales by Country (2021-2026) & (k units) Table 214. SAMEA HPV Vaccines Sales by Country (2027-2032) & (k units) Table 215. SAMEA HPV Vaccines Sales Price by Country (2021-2026) & (US$/unit) Table 216. SAMEA HPV Vaccines Sales Price by Country (2027-2032) & (US$/unit) Table 217. Brazil HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 218. Argentina HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 219. Chile HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 220. Colombia HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 221. Peru HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 222. Saudi Arabia HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 223. Israel HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 224. UAE HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 225. Turkey HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 226. Iran HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 227. Egypt HPV Vaccines Revenue (2021-2032) & (US$ Million) Table 228. Key Raw Materials Table 229. Raw Materials Key Suppliers Table 230. HPV Vaccines Distributors List Table 231. HPV Vaccines Customers List Table 232. Research Programs/Design for This Report Table 233. Authors List of This Report Table 234. Secondary Sources Table 235. Primary Sources List of Figures Figure 1. HPV Vaccines Image Figure 2. Global HPV Vaccines Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HPV Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 4. Adolescents Image Figure 5. Adults Image Figure 6. Global HPV Vaccines Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global HPV Vaccines Market Size Share 2021 VS 2025 VS 2032 Figure 8. Male Image Figure 9. Female Image Figure 10. Global HPV Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global HPV Vaccines Revenue (2021-2032) & (US$ Million) Figure 12. Global HPV Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global HPV Vaccines Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global HPV Vaccines Revenue Market Share by Region (2021-2032) Figure 15. Global HPV Vaccines Sales (2021-2032) & (k units) Figure 16. Global HPV Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global HPV Vaccines Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico HPV Vaccines Sales YoY (2021-2032) & (k units) Figure 19. Europe HPV Vaccines Sales YoY (2021-2032) & (k units) Figure 20. China HPV Vaccines Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) HPV Vaccines Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa HPV Vaccines Sales YoY (2021-2032) & (k units) Figure 23. Global HPV Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global HPV Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global HPV Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global HPV Vaccines Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global HPV Vaccines Revenue Market Share by Type (2021-2032) Figure 29. Global HPV Vaccines Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global HPV Vaccines Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global HPV Vaccines Sales Market Share by Type (2021-2032) Figure 32. Global HPV Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global HPV Vaccines Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global HPV Vaccines Revenue Market Share by Application (2021-2032) Figure 35. Global HPV Vaccines Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global HPV Vaccines Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global HPV Vaccines Sales Market Share by Application (2021-2032) Figure 38. North America HPV Vaccines Revenue Share by Type (2021-2032) Figure 39. North America HPV Vaccines Sales Share by Type (2021-2032) Figure 40. North America HPV Vaccines Revenue Share by Application (2021-2032) Figure 41. North America HPV Vaccines Sales Share by Application (2021-2032) Figure 42. North America HPV Vaccines Revenue Share by Country (2021-2032) Figure 43. North America HPV Vaccines Sales Share by Country (2021-2032) Figure 44. Europe HPV Vaccines Revenue Share by Type (2021-2032) Figure 45. Europe HPV Vaccines Sales Share by Type (2021-2032) Figure 46. Europe HPV Vaccines Revenue Share by Application (2021-2032) Figure 47. Europe HPV Vaccines Sales Share by Application (2021-2032) Figure 48. Europe HPV Vaccines Revenue Share by Country (2021-2032) Figure 49. Europe HPV Vaccines Sales Share by Country (2021-2032) Figure 50. China HPV Vaccines Revenue Share by Type (2021-2032) Figure 51. China HPV Vaccines Sales Share by Type (2021-2032) Figure 52. China HPV Vaccines Revenue Share by Application (2021-2032) Figure 53. China HPV Vaccines Sales Share by Application (2021-2032) Figure 54. Asia HPV Vaccines Revenue Share by Type (2021-2032) Figure 55. Asia HPV Vaccines Sales Share by Type (2021-2032) Figure 56. Asia HPV Vaccines Revenue Share by Application (2021-2032) Figure 57. Asia HPV Vaccines Sales Share by Application (2021-2032) Figure 58. Asia HPV Vaccines Revenue Share by Country (2021-2032) Figure 59. Asia HPV Vaccines Sales Share by Country (2021-2032) Figure 60. SAMEA HPV Vaccines Revenue Share by Type (2021-2032) Figure 61. SAMEA HPV Vaccines Sales Share by Type (2021-2032) Figure 62. SAMEA HPV Vaccines Revenue Share by Application (2021-2032) Figure 63. SAMEA HPV Vaccines Sales Share by Application (2021-2032) Figure 64. SAMEA HPV Vaccines Revenue Share by Country (2021-2032) Figure 65. SAMEA HPV Vaccines Sales Share by Country (2021-2032) Figure 66. HPV Vaccines Value Chain Figure 67. Manufacturing Cost Structure Figure 68. HPV Vaccines Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Adolescents
  • Adults
Applications
  • Male
  • Female
Companies covered
  • Johnson & Johnson
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Serum Institute
  • Sanofi Pasteur
  • MedImmune
  • Emergent BioSolutions
  • CSL
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HPV Vaccines Market by Type
  3. 1.2.1 Global HPV Vaccines Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Adolescents
  5. 1.2.3 Adults
  6. 1.3 HPV Vaccines Market by Application
  7. 1.3.1 Global HPV Vaccines Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Male
  9. 1.3.3 Female
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 HPV Vaccines Market Dynamics
  1. 2.1 HPV Vaccines Industry Trends
  2. 2.2 HPV Vaccines Industry Drivers
  3. 2.3 HPV Vaccines Industry Opportunities and Challenges
  4. 2.4 HPV Vaccines Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global HPV Vaccines Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global HPV Vaccines Revenue by Region
  3. 3.2.1 Global HPV Vaccines Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HPV Vaccines Revenue by Region (2021-2026)
  5. 3.2.3 Global HPV Vaccines Revenue by Region (2027-2032)
  6. 3.2.4 Global HPV Vaccines Revenue Market Share by Region (2021-2032)
  7. 3.3 Global HPV Vaccines Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global HPV Vaccines Sales by Region
  9. 3.4.1 Global HPV Vaccines Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global HPV Vaccines Sales by Region (2021-2026)
  11. 3.4.3 Global HPV Vaccines Sales by Region (2027-2032)
  12. 3.4.4 Global HPV Vaccines Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global HPV Vaccines Revenue by Manufacturers
  2. 4.1.1 Global HPV Vaccines Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global HPV Vaccines Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global HPV Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HPV Vaccines Sales by Manufacturers
  6. 4.2.1 Global HPV Vaccines Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global HPV Vaccines Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global HPV Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global HPV Vaccines Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global HPV Vaccines Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global HPV Vaccines Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global HPV Vaccines Manufacturers, Product Type & Application
  13. 4.7 Global HPV Vaccines Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global HPV Vaccines Market CR5 and HHI
  16. 4.8.2 2025 HPV Vaccines Tier 1, Tier 2, and Tier 3
5 HPV Vaccines Market by Type
  1. 5.1 Global HPV Vaccines Revenue by Type
  2. 5.1.1 Global HPV Vaccines Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global HPV Vaccines Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global HPV Vaccines Revenue Market Share by Type (2021-2032)
  5. 5.2 Global HPV Vaccines Sales by Type
  6. 5.2.1 Global HPV Vaccines Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global HPV Vaccines Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global HPV Vaccines Sales Market Share by Type (2021-2032)
  9. 5.3 Global HPV Vaccines Price by Type
6 HPV Vaccines Market by Application
  1. 6.1 Global HPV Vaccines Revenue by Application
  2. 6.1.1 Global HPV Vaccines Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global HPV Vaccines Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global HPV Vaccines Revenue Market Share by Application (2021-2032)
  5. 6.2 Global HPV Vaccines Sales by Application
  6. 6.2.1 Global HPV Vaccines Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global HPV Vaccines Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global HPV Vaccines Sales Market Share by Application (2021-2032)
  9. 6.3 Global HPV Vaccines Price by Application
7 Company Profiles
  1. 7.1 Johnson & Johnson
  2. 7.1.1 Johnson & Johnson Company Information
  3. 7.1.2 Johnson & Johnson Business Overview
  4. 7.1.3 Johnson & Johnson HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Johnson & Johnson HPV Vaccines Product Portfolio
  6. 7.1.5 Johnson & Johnson Recent Developments
  7. 7.2 Merck
  8. 7.2.1 Merck Company Information
  9. 7.2.2 Merck Business Overview
  10. 7.2.3 Merck HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Merck HPV Vaccines Product Portfolio
  12. 7.2.5 Merck Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer HPV Vaccines Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline HPV Vaccines Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Serum Institute
  26. 7.5.1 Serum Institute Company Information
  27. 7.5.2 Serum Institute Business Overview
  28. 7.5.3 Serum Institute HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Serum Institute HPV Vaccines Product Portfolio
  30. 7.5.5 Serum Institute Recent Developments
  31. 7.6 Sanofi Pasteur
  32. 7.6.1 Sanofi Pasteur Company Information
  33. 7.6.2 Sanofi Pasteur Business Overview
  34. 7.6.3 Sanofi Pasteur HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Sanofi Pasteur HPV Vaccines Product Portfolio
  36. 7.6.5 Sanofi Pasteur Recent Developments
  37. 7.7 MedImmune
  38. 7.7.1 MedImmune Company Information
  39. 7.7.2 MedImmune Business Overview
  40. 7.7.3 MedImmune HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 MedImmune HPV Vaccines Product Portfolio
  42. 7.7.5 MedImmune Recent Developments
  43. 7.8 Emergent BioSolutions
  44. 7.8.1 Emergent BioSolutions Company Information
  45. 7.8.2 Emergent BioSolutions Business Overview
  46. 7.8.3 Emergent BioSolutions HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Emergent BioSolutions HPV Vaccines Product Portfolio
  48. 7.8.5 Emergent BioSolutions Recent Developments
  49. 7.9 CSL
  50. 7.9.1 CSL Company Information
  51. 7.9.2 CSL Business Overview
  52. 7.9.3 CSL HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 CSL HPV Vaccines Product Portfolio
  54. 7.9.5 CSL Recent Developments
  55. 7.10 Astellas Pharma
  56. 7.10.1 Astellas Pharma Company Information
  57. 7.10.2 Astellas Pharma Business Overview
  58. 7.10.3 Astellas Pharma HPV Vaccines Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Astellas Pharma HPV Vaccines Product Portfolio
  60. 7.10.5 Astellas Pharma Recent Developments
8 North America
  1. 8.1 North America HPV Vaccines Market Size by Type
  2. 8.1.1 North America HPV Vaccines Revenue by Type (2021-2032)
  3. 8.1.2 North America HPV Vaccines Sales by Type (2021-2032)
  4. 8.1.3 North America HPV Vaccines Price by Type (2021-2032)
  5. 8.2 North America HPV Vaccines Market Size by Application
  6. 8.2.1 North America HPV Vaccines Revenue by Application (2021-2032)
  7. 8.2.2 North America HPV Vaccines Sales by Application (2021-2032)
  8. 8.2.3 North America HPV Vaccines Price by Application (2021-2032)
  9. 8.3 North America HPV Vaccines Market Size by Country
  10. 8.3.1 North America HPV Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America HPV Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America HPV Vaccines Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe HPV Vaccines Market Size by Type
  2. 9.1.1 Europe HPV Vaccines Revenue by Type (2021-2032)
  3. 9.1.2 Europe HPV Vaccines Sales by Type (2021-2032)
  4. 9.1.3 Europe HPV Vaccines Price by Type (2021-2032)
  5. 9.2 Europe HPV Vaccines Market Size by Application
  6. 9.2.1 Europe HPV Vaccines Revenue by Application (2021-2032)
  7. 9.2.2 Europe HPV Vaccines Sales by Application (2021-2032)
  8. 9.2.3 Europe HPV Vaccines Price by Application (2021-2032)
  9. 9.3 Europe HPV Vaccines Market Size by Country
  10. 9.3.1 Europe HPV Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe HPV Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe HPV Vaccines Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China HPV Vaccines Market Size by Type
  2. 10.1.1 China HPV Vaccines Revenue by Type (2021-2032)
  3. 10.1.2 China HPV Vaccines Sales by Type (2021-2032)
  4. 10.1.3 China HPV Vaccines Price by Type (2021-2032)
  5. 10.2 China HPV Vaccines Market Size by Application
  6. 10.2.1 China HPV Vaccines Revenue by Application (2021-2032)
  7. 10.2.2 China HPV Vaccines Sales by Application (2021-2032)
  8. 10.2.3 China HPV Vaccines Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HPV Vaccines Market Size by Type
  2. 11.1.1 Asia HPV Vaccines Revenue by Type (2021-2032)
  3. 11.1.2 Asia HPV Vaccines Sales by Type (2021-2032)
  4. 11.1.3 Asia HPV Vaccines Price by Type (2021-2032)
  5. 11.2 Asia HPV Vaccines Market Size by Application
  6. 11.2.1 Asia HPV Vaccines Revenue by Application (2021-2032)
  7. 11.2.2 Asia HPV Vaccines Sales by Application (2021-2032)
  8. 11.2.3 Asia HPV Vaccines Price by Application (2021-2032)
  9. 11.3 Asia HPV Vaccines Market Size by Country
  10. 11.3.1 Asia HPV Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia HPV Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia HPV Vaccines Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HPV Vaccines Market Size by Type
  2. 12.1.1 SAMEA HPV Vaccines Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA HPV Vaccines Sales by Type (2021-2032)
  4. 12.1.3 SAMEA HPV Vaccines Price by Type (2021-2032)
  5. 12.2 SAMEA HPV Vaccines Market Size by Application
  6. 12.2.1 SAMEA HPV Vaccines Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA HPV Vaccines Sales by Application (2021-2032)
  8. 12.2.3 SAMEA HPV Vaccines Price by Application (2021-2032)
  9. 12.3 SAMEA HPV Vaccines Market Size by Country
  10. 12.3.1 SAMEA HPV Vaccines Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA HPV Vaccines Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA HPV Vaccines Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 HPV Vaccines Value Chain Analysis
  2. 13.1.1 HPV Vaccines Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 HPV Vaccines Production Mode & Process
  6. 13.2 HPV Vaccines Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 HPV Vaccines Distributors
  9. 13.2.3 HPV Vaccines Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst